Business Wire

Orthocell Receives CE Mark for CelGro®

Jaa

Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce receipt of European regulatory approval (CE Mark) for its CelGro® collagen medical device. CelGro®, for a range of dental bone and soft tissue regeneration procedures, can now be marketed and sold within the European Union (EU).

“European regulatory approval for CelGro® marks a major milestone for Orthocell as it enables commercial rollout in the lucrative dental bone and soft tissue regeneration market, where there is a significant and growing demand and market opportunity. This provides a strong foundation for Orthocell to progress additional dental regulatory applications in key markets, such as the US, Japan and Australia,” Orthocell Managing Director Paul Anderson said.

“The CE Mark also validates the potential of the entire technology platform by endorsing CelGro®’s clinical performance and quality manufacturing. In addition, the achievement of this CE Mark supports regulatory applications for additional indications.”

CE Mark approval for dental bone and soft tissue regeneration

Orthocell has received market authorisation (CE Mark) of CelGro® collagen scaffold medical device in the EU for dental bone and soft tissue applications. The CE Mark allows CelGro® to be sold within EU countries, validates CelGro®’s quality manufacturing and product performance, and provides a strong foundation for indication expansion and regulatory approvals.

Orthocell has a clear commercialisation strategy in place to drive initial sales of CelGro® and the Company is in discussion with strategic commercial partners for product distribution in Europe and other key regions. Orthocell is also currently in discussions with selected Key Opinion Leaders in the dental and bone regeneration fields, who play an important role in driving broader market adoption.

CelGro® is manufactured by Orthocell at its quality controlled Good Manufacturing Practices (GMP) licensed facility in WA, using the Company’s proprietary SMRTTM tissue engineering process, developed in conjunction with Professor Minghao Zheng and the University of Western Australia. CelGro® plays a critical role in dental bone and soft tissue regeneration therapy as it offers superior functionality over existing products for improved tissue repair.

Key Opinion Leader, Dr Brent Allan (oral & maxillofacial surgeon) commented, “CelGro® is an exciting new product with clear advantages over the available alternatives. I prefer to use CelGro® over existing scaffolds. It is easy to handle and enables a high quality tissue repair.”

CelGro®’s dental addressable market is estimated to be worth more than US$600 million per annum, with approximately 1.5m procedures that utilize these types of scaffolds being completed each year. Market growth is expected to be underpinned by an aging population, significant growing demand for dental therapies and the surgeons’ preference for quality and functional bio-absorbable membranes. With the CE Mark achieved, Orthocell is well positioned to capture a significant share of a large and growing market given CelGro® has demonstrated in clinical studies, superior bone regeneration.

Expanding CelGro® indications

Securing the CE Mark approval for the dental and soft tissue application of CelGro® is a critical milestone for Orthocell. The CE Mark regulatory approval further validates the CelGro® technology platform and can be leveraged across a range of additional applications including:

  • neurological: peripheral nerve repair;
  • orthopaedic: tendon, ligaments, cartilage and bone; and
  • other: general surgery (including hernia repair) and urogynaelogical.

CelGro® is targeted to a variety of orthopedic, reconstructive and surgical applications. The company believes it represents a breakthrough in soft tissue reconstruction and offers significant global commercial potential in its existing addressable markets of bone, tendon, nerve and cartilage as well as much wider applications in general surgical and soft tissue reconstructive applications.

Contact information

General enquiries
Orthocell Limited
Paul Anderson, +61 8 9360 2888
Managing Director
paulanderson@orthocell.com.au
or
Investor and Media enquiries
WE Buchan
Ben Walsh, + 61 411 520 012
bwalsh@buchanwe.com.au

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Telstra and Sigma Systems to Present Catalog-Driven Dynamic Offer Creation at TM Forum Live! Asia21.11.2017 13:00Tiedote

Sigma Systems, the global leader in catalog-driven software, announced today that it will be presenting at TM Forum Live! Asia in partnership with Telstra, Australia’s leading telecommunications and technology company. Sigma’s Chief Technology Officer (CTO), Catherine Michel, will be on stage with Telstra's Chief Technology Officer (Customer), Dr. Fawad Nazir, to discuss why traditional service providers must adopt a “digital native” mindset and the corresponding operational agility to thrive in a digital economy. The ability to create and launch new offers in minutes, rather than months, and rapidly enable new business models is critical to an operator’s success. “Sigma Catalog creates the ability to sell through and then orchestrate the fulfillment of an order from different channels into the full B/OSS stack and across various delivery networks. The product’s Offer Canvas

Seoul Semiconductor First in the World to Receive Low Risk Eye Safety Certification for its Natural Light LED SunLike21.11.2017 12:00Tiedote

The world-leading LED company Seoul Semiconductor (Head office: Ansan-si, Korea, CEO: Chung Hoon Lee, hereinafter Seoul Semiconductor) announced that SunLike, which implements light which comes closest to sunlight, received an RG-1 Eye Safety certification based on the safety of its light source and was recognized for the highest level of safety amongst 25W COB type LED. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005036/en/ 25W SunLike light source which acquired RG-1 grade in Eye Safety certification (Photo: Business Wire) Eye Safety certification is a rating based on safety from analyzing the LED wavelengths. In Europe, where top priority is placed on the safety of lighting, Eye Safety certification is essential and the light source must be higher than RG-3 level, otherwise eye sight may b

FlexTrade Introduces Enhanced Cross-OMS Aggregation for MiFID II21.11.2017 12:00Tiedote

FlexTrade Systems (@FlexTrade), a global leader in cross-asset execution and order management systems, today announced the rollout of an enhanced version of its multi-OMS aggregation functionality, an in-built feature of the FlexTRADER EMS, which allows users to merge and net orders across multiple OMSs regardless of the underlying version or implementation. “With a number of major asset manager mergers over the past few years bringing together a variety of OMS technologies, we have seen a surge of interest in FlexTRADER’s unique abilities in cross-OMS order aggregation,” said Oliver Boatfield, EMEA Sales Director at FlexTrade UK. Along with the ability to dynamically merge orders within and across OMSs, FlexTRADER provides highly configurable allocation logic with several out-of-the-box rules, including LIFO, FIFO, pro-rata and optimal average pricing. I

Starr Companies Announces Aviation Insurance Agreement with SMARTT MGA21.11.2017 11:00Tiedote

Starr Companies today announced an agreement with SMARTT MGA to act as Agents for Starr International (Europe) Limited to provide automated quotes and policy documentation for light general aviation business. “We have built a close and fruitful relationship with SMARTT and are happy that we have formalized this arrangement,” stated Jim Herbert, chief underwriting officer, aviation. “We believe our StarrLink International platform will bring significant efficiencies to the way aviation business is placed. We look forward to expanding our product offerings through SMARTT MGA in the near future.” Michal Chmielewski, chief executive officer, SMARTT MGA, stated, “Most quotes, binding and policy documentation issuance take only a few minutes to produce through the StarrLink platform – changing the way aviation insurance is purchased.” SMARTT MGA is a part of SMARTT Grou

Octapharma Donates 30.5 Million International Units of Its Medicine Nuwiq to Treat People with Haemophilia in Developing Countries21.11.2017 11:00Tiedote

2017: Octapharma is pleased to announce the completion of a charitable donation of 30.5 million international units of its human cell-line derived recombinant factor VIII product, Nuwiq®, in collaboration with Project SHARE, North Andover, Massachusetts (USA). This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005038/en/ Donation in Nepal of human cell-line derived recombinant factor VIII product Nuwiq (Photo: Business Wire) Up to 75% of the world's estimated 400,000 people with haemophilia have little or no access to treatment that resolves life- and limb-threatening bleeds, and enables surgery and rehabilitation. A humanitarian program, Project SHARE facilitates the donation of blood-clotting factor products for the treatment of people with haemophilia in need of factor replacement therapy

"Complete Your Game!"The 13th Global Game Exhibition G-STAR 2017 Opens to Success21.11.2017 06:39Tiedote

The start of the G-STAR Game Show and Trade All Round 2017, an international game exhibition that examines the global gaming industry and its future possibilities, was announced at BEXCO, Busan, on November 16th. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171120006218/en/ Opening Ceremony of G-STAR 2017 (Photo: Business Wire) Celebrating its 13th anniversary this year, G-STAR 2017 is hosted by the Korea Game Industry Association (K-GAMES) and co-organized by the G-STAR Organizing Committee and the Busan IT Industry Promotion Agency. It runs for 4 days from the 16th to 19th (Sun). This year’s G-STAR 2017 has been a record success, bringing together 693 companies from 35 countries and exhibiting 2,857 booths - a 5.0% increase from the previous year. G-STAR 2017

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme